Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Clémence Verdier

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|August 9, 2024
Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III TrialsFlorian Lemaitre, Sébastien Lalanne, Marie-Clémence Verdier
Therapie|March 9, 2010
[Therapeutic drug monitoring of vigabatrin]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|March 9, 2010
[Therapeutic drug monitoring of felbamate]Olivier Tribut, Danièle Bentué-Ferrer, Marie-Clémence Verdier, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|August 2, 2012
[Therapeutic drug monitoring of lacosamide]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier
Therapie|August 2, 2012
[Therapeutic drug monitoring of stiripentol]Marie-Clémence Verdier, Olivier Tribut, Danièle Bentué-Ferrer
Therapie|August 2, 2012
[Therapeutic drug monitoring of rufinamide]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier
Therapie|March 9, 2010
[Therapeutic drug monitoring of topiramate]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|March 9, 2010
[Therapeutic drug monitoring of tiagabine]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|August 9, 2024
Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III TrialsFlorian Lemaitre, Sébastien Lalanne, Marie-Clémence Verdier
Therapie|March 9, 2010
[Therapeutic drug monitoring of vigabatrin]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|March 9, 2010
[Therapeutic drug monitoring of felbamate]Olivier Tribut, Danièle Bentué-Ferrer, Marie-Clémence Verdier, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|August 2, 2012
[Therapeutic drug monitoring of lacosamide]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier
Therapie|August 2, 2012
[Therapeutic drug monitoring of stiripentol]Marie-Clémence Verdier, Olivier Tribut, Danièle Bentué-Ferrer
Therapie|August 2, 2012
[Therapeutic drug monitoring of rufinamide]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier
Therapie|March 9, 2010
[Therapeutic drug monitoring of topiramate]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|March 9, 2010
[Therapeutic drug monitoring of tiagabine]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Pageof 10